Anemia of Chronic Disease
Understand Anemia of Chronic Disease (ACD), also known as Anemia of Inflammation or Anemia of Chronic Illness. This resource provides information on diagnosis, clinical documentation, and medical coding for anemia chronic disease, crucial for healthcare professionals and medical coding specialists. Learn about the connection between ACD and inflammation, relevant lab values, and best practices for accurate medical record keeping.
Anemia caused by chronic inflammation, infection, or malignancy, impairing iron utilization.
Fatigue, weakness, shortness of breath, pale skin, headaches, dizziness.
Rheumatoid arthritis, chronic kidney disease, inflammatory bowel disease, cancer.
ICD-10 Code Families
Complete code families applicable to D63.1
When to use each related code
| Description | When to use |
|---|---|
| Low red blood cells due to chronic disease. | Code for anemia caused by inflammation, infection, or chronic illness. Consider underlying cause. |
| Low iron, leading to reduced red blood cell production. | Code when iron deficiency is the primary cause of anemia. Check ferritin and transferrin levels. |
| Vitamin B12 deficiency impairs red blood cell development. | Code when B12 deficiency causes anemia. Consider pernicious anemia, dietary causes. |
Best-practice checklist
- ✓Document underlying chronic disease (ICD-10 code).
- ✓Specify type of anemia (e.g., normocytic, normochromic).
- ✓Hb/Hct, RBC indices, iron studies results.
- ✓Rule out other anemia causes (iron deficiency, B12/folate).
- ✓Document treatment plan and rationale (if applicable).
Common pitfalls to avoid
Coding anemia of chronic disease without specifying the underlying etiology (e.g., rheumatoid arthritis) leads to inaccurate reporting and potential DRG misassignment.
Misdiagnosing anemia of chronic disease as iron deficiency anemia can lead to inappropriate treatment and inaccurate quality metrics related to anemia management.
Insufficient documentation of the chronic condition causing the anemia may lead to coding queries, denials, and compliance issues during audits.
Best-practice tips
- 01Treat underlying disease. Code ICD-10 D63.0.
- 02Document iron studies, ESR, CRP. CDI: specificity.
- 03Erythropoiesis-stimulating agents if indicated. HCC coding guidelines.
- 04Optimize nutrition, hydration status. ICD-10-CM coding best practices.
- 05Transfusion rarely needed. Document rationale for HCC compliance.
Step-by-step checklist
- 1
Verify underlying chronic disease diagnosis (e.g., ICD-10 D63.0, rheumatoid arthritis).
- 2
Confirm normocytic or microcytic anemia with CBC and peripheral smear review.
- 3
Check serum iron, ferritin, transferrin saturation, and total iron-binding capacity.
- 4
Exclude other anemia causes (iron deficiency, B12/folate, hemolysis) via appropriate testing.
Ready-to-paste narrative
Patient presents with signs and symptoms suggestive of anemia of chronic disease (ACD), also referred to as anemia of inflammation or anemia of chronic illness. The patient reports fatigue, weakness, and decreased exercise tolerance. Physical examination reveals pallor. Relevant laboratory findings include a normocytic or slightly microcytic anemia with a low hemoglobin and hematocrit. Serum iron levels are low, while ferritin levels are normal or elevated, differentiating this from iron deficiency anemia. Total iron binding capacity (TIBC) is typically low or normal. The underlying chronic disease, diagnosed as [Insert specific chronic disease e.g., rheumatoid arthritis, chronic kidney disease, inflammatory bowel disease], is considered the etiologic factor contributing to the anemia. The patient's current medication list includes [List current medications]. Differential diagnoses considered included iron deficiency anemia, thalassemia, and sideroblastic anemia. Based on the clinical presentation, laboratory results, and underlying chronic disease, the diagnosis of anemia of chronic disease is established. The treatment plan will focus on managing the underlying chronic disease. Further laboratory monitoring of hemoglobin, hematocrit, iron studies, and inflammatory markers will be performed to assess response to treatment. Patient education provided on anemia of chronic disease, its relationship to the underlying condition, and the importance of adherence to the treatment plan for the primary disease. ICD-10 code D63.8 (Anemia in other chronic diseases classified elsewhere) is applicable. Follow-up scheduled in [ timeframe e.g., four weeks] to reassess the anemia and the underlying condition.
Common questions and answers
How can I differentiate Anemia of Chronic Disease (ACD) from Iron Deficiency Anemia (IDA) in patients with chronic inflammatory conditions?+
Differentiating Anemia of Chronic Disease (ACD) from Iron Deficiency Anemia (IDA) in patients with chronic inflammatory conditions can be challenging due to overlapping symptoms. Key distinguishing features include: serum ferritin levels (typically normal or elevated in ACD, low in IDA), transferrin saturation (low in both, but often higher in ACD), total iron-binding capacity (TIBC) (low in ACD, high in IDA), and soluble transferrin receptor (sTfR) (normal or slightly elevated in ACD, elevated in IDA). Furthermore, evaluating the patient's inflammatory markers (e.g., C-reactive protein, erythrocyte sedimentation rate) can help identify underlying inflammation contributing to ACD. Bone marrow examination, though less commonly performed, may reveal increased iron stores in ACD despite reduced erythropoiesis. Consider implementing a diagnostic algorithm incorporating these parameters for accurate differentiation and targeted treatment. Explore how a comprehensive approach to iron studies interpretation can improve diagnostic accuracy in these complex cases.
What are the evidence-based management strategies for Anemia of Chronic Disease (ACD) in patients with rheumatoid arthritis?+
Managing Anemia of Chronic Disease (ACD) in patients with rheumatoid arthritis requires a multi-faceted approach. First, prioritize optimizing treatment of the underlying rheumatoid arthritis, as controlling the inflammatory process can improve anemia. While iron supplementation is generally not recommended in ACD due to impaired iron utilization and potential risks, it may be considered in select cases with true iron deficiency coexisting with ACD, after careful evaluation of iron indices. Erythropoiesis-stimulating agents (ESAs) like erythropoietin or darbepoetin alfa can be beneficial, particularly in patients with moderate to severe anemia and inadequate response to disease-modifying antirheumatic drugs (DMARDs). However, ESA use needs careful consideration of potential risks, including cardiovascular events. Learn more about the potential benefits and risks of ESAs in ACD management to individualize patient care. Consider implementing a treatment plan that balances managing the underlying inflammatory condition and addressing the anemia itself.
What are the common pitfalls in diagnosing and managing anemia of chronic illness (ACI) in patients with chronic kidney disease (CKD)?+
Common pitfalls in diagnosing and managing anemia of chronic illness (ACI), also known as anemia of inflammation, in patients with chronic kidney disease (CKD) include misattributing the anemia solely to CKD without considering the contribution of inflammation. Another pitfall is relying solely on hemoglobin levels without a comprehensive assessment of iron status, including ferritin, transferrin saturation, and other iron indices. Furthermore, overlooking other potential causes of anemia in CKD, such as nutritional deficiencies (e.g., vitamin B12, folate) or blood loss, can lead to inadequate management. Inappropriately administering iron supplementation without confirming true iron deficiency can be detrimental in ACD. Explore how optimizing CKD management and addressing contributing inflammatory factors can improve anemia outcomes. Learn more about the interplay between CKD, inflammation, and anemia to avoid these diagnostic and management pitfalls.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.